Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study : The Lancet Oncology
Links shared publicly online about this topic.
- 521total visits
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study : The Lancet Oncology
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. By - Dr Hedy L Kindler MD, Tatsuya Ioka MD, D...
View full resource at thelancet.com
Tags: Pancreatic Disease, Cancer, Cancer Medication, Pancreatic Cancer, Phase 3 Clinical Trial, Gemzar, Oncology
Most Recently Shared on February 8, 2011 at 3:48 pm By:
Reporting a phase 3 trial of gemcitabine plus axitinib in patients with advanced pancreatic cancer. http://fb.thelancet.com/JLh
Advertisement
